Medcura Inc - Product Pipeline Analysis, 2024 Update

Summary


Medcura Inc (Medcura), is a medical device company that provides products for the treatment of acute wounds. The company's products include surgical hemostasis products, military and trauma products, consumer products, among others. Its consumer products include woundgel and woundwash. Medcura markets its products under the brands LifeGel, LifeCoat, LifeSheet, LifeFib, Life Patch, LifeFoam, LifeDust, LifePutty, RapidSeal, SealIt, WashIt. It's products are used in clinical settings, routine lacerations, nosebleeds, traumatic injuries, surgical bleeds, burns and diabetic ulcers among others. Medcura is headquartered in Riverdale, Maryland, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Medcura Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note:Some sections may be missing if data is unavailable for the company


Medcura Inc Company Overview
Medcura Inc Company Snapshot
Medcura Inc Pipeline Products and Ongoing Clinical Trials Overview
Medcura Inc – Pipeline Analysis Overview
Medcura Inc - Key Facts
Medcura Inc - Major Products and Services
Medcura Inc Pipeline Products by Development Stage
Medcura Inc Pipeline Products Overview
Hemogrip Foam
Hemogrip Foam Product Overview
LifeDust
LifeDust Product Overview
LifeFoam
LifeFoam Product Overview
LifeGel
LifeGel Product Overview
Surgicura
Surgicura Product Overview
Trauma Gel-e
Trauma Gel-e Product Overview
Medcura Inc - Key Competitors
Medcura Inc - Key Employees
Medcura Inc - Locations And Subsidiaries
Head Office
Recent Developments
Medcura Inc, Recent Developments
Sep 25, 2024: Medcura's Hemostatic Agent Lifegel Wins 2024 Spine Technology Award
Jan 12, 2023: Medcura receives breakthrough device designation for its LifeGel absorbable surgical hemostat
Sep 01, 2022: Injectable non-thrombin foam increases survival rates for severe internal bleeding in recent research study
Jul 12, 2021: Medcura launches a new class of high-performance, antibacterial hemostats
Apr 07, 2021: Medcura publishes successful results from clinical study
Feb 23, 2021: Medcura expands Internal Hemostat Program with a follow-on grant from the U.S. Military
Dec 19, 2019: gel-e changes its name to Medcura
Oct 31, 2019: Continued expansion of gel-e's consumer products label
Apr 03, 2019: Successful first use of gel-e in a surgical model
Jan 21, 2019: gel-e expands patent estate
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Medcura Inc Pipeline Products and Ongoing Clinical Trials Overview
Medcura Inc Pipeline Products by Equipment Type
Medcura Inc Pipeline Products by Indication
Medcura Inc, Key Facts
Medcura Inc, Major Products and Services
Medcura Inc Number of Pipeline Products by Development Stage
Medcura Inc Pipeline Products Summary by Development Stage
Hemogrip Foam - Product Status
Hemogrip Foam - Product Description
LifeDust - Product Status
LifeDust - Product Description
LifeFoam - Product Status
LifeFoam - Product Description
LifeGel - Product Status
LifeGel - Product Description
Surgicura - Product Status
Surgicura - Product Description
Trauma Gel-e - Product Status
Trauma Gel-e - Product Description
Medcura Inc, Key Employees
Glossary
List of Figures
Medcura Inc Pipeline Products by Equipment Type
Medcura Inc Pipeline Products by Development Stage

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings